X-136209951-G-C
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2
The NM_001159699.2(FHL1):āc.817G>Cā(p.Val273Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000356 in 1,208,774 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 14 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 10/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001159699.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FHL1 | NM_001159699.2 | c.817G>C | p.Val273Leu | missense_variant | 6/6 | ENST00000370683.6 | NP_001153171.1 | |
FHL1 | NM_001159702.3 | c.969G>C | p.Pro323Pro | synonymous_variant | 8/8 | ENST00000394155.8 | NP_001153174.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FHL1 | ENST00000370683.6 | c.817G>C | p.Val273Leu | missense_variant | 6/6 | 1 | NM_001159699.2 | ENSP00000359717.1 | ||
FHL1 | ENST00000394155.8 | c.969G>C | p.Pro323Pro | synonymous_variant | 8/8 | 5 | NM_001159702.3 | ENSP00000377710.2 |
Frequencies
GnomAD3 genomes AF: 0.0000452 AC: 5AN: 110563Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 32807
GnomAD3 exomes AF: 0.0000436 AC: 8AN: 183526Hom.: 0 AF XY: 0.0000589 AC XY: 4AN XY: 67954
GnomAD4 exome AF: 0.0000346 AC: 38AN: 1098211Hom.: 0 Cov.: 33 AF XY: 0.0000385 AC XY: 14AN XY: 363565
GnomAD4 genome AF: 0.0000452 AC: 5AN: 110563Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 32807
ClinVar
Submissions by phenotype
X-linked myopathy with postural muscle atrophy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2024 | This sequence change replaces valine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 257 of the FHL1 protein (p.Val257Leu). This variant is present in population databases (rs190006104, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with FHL1-related conditions. ClinVar contains an entry for this variant (Variation ID: 838540). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The leucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 24, 2023 | The p.V257L variant (also known as c.769G>C), located in coding exon 5 of the FHL1 gene, results from a G to C substitution at nucleotide position 769. The valine at codon 257 is replaced by leucine, an amino acid with highly similar properties. Based on data from gnomAD, the C allele has an overall frequency of <0.01% (8/183526) total alleles studied, with 4 hemizygote(s) observed. The highest observed frequency was 0.01% (3/27431) of Latino alleles. This amino acid position is poorly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 08, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at